TAG:
private payer
Labs In United Kingdom Study U.S., Canadian Labs
By Robert Michel | From the Volume X No. 2 – February 10, 2003 Issue
CEO SUMMARY: It was a groundbreaking first for both sides of the Atlantic. Senior pathologists and laboratory directors in the United Kingdom spent two days learning from their North American counterparts about the challenges and difficulties in laboratory consolidation and regionalizatio…
New Trends in 2003 Affect Clinical Lab Services
By Robert Michel | From the Volume X No. 1 – January 20, 2003 Issue
CEO SUMMARY: Here’s our current list of macro trends that affect clinical laboratories, updated from the last list in January 2000. One bold prediction is that Medicare, as we know it, is on the verge of a major meltdown. Employers and consumers are also new forces to be reckoned with b…
Tenet’s Outlier Medicare Fees Put It in Unwelcome Spotlight
By Robert Michel | From the Volume IX No. 16 – November 18, 2002 Issue
MEDICARE CODING AND BILLING policies at Tenet Healthcare Corporation have come under scrutiny by both Medicare officials and Wall Street analysts. Attention is centered around how Tenet aggressively pursued Medicare reimbursement under “outlier” formulas. These formulas are designed to supplemen…
Read “Waiver of Charges” for What It Is: FREE!
By R. Lewis Dark | From the Volume IX No. 12 – August 26, 2002 Issue
TODAY I AM AN OLD CURMUDGEON WHO IS IN HIGH DUDGEON. What’s got my dander up is the disturbing revelation in this issue of THE DARK REPORT about the willingness by some of our industry’s biggest companies to use “free testing” as a way to protect and build market share. (See pages 2-8…
Big Fight is Brewing Over Lab Test Reimbursement
By R. Lewis Dark | From the Volume IX No. 8 – June 3, 2002 Issue
BY NOW, MOST LAB EXECUTIVES AND PATHOLOGISTS AGREE that Medicare Part B fees and reimbursement guidelines for lab testing have just about become de facto national standards. That’s because private payers increasingly use Medicare as the basis for building their own pricing and reimbursement guideli…
CPI Lab Fee Adjustment Threatened by New Bill
By Robert Michel | From the Volume IX No. 8 – June 3, 2002 Issue
CEO SUMMARY: Once again, the laboratory testing industry has been singled out as a healthcare “whipping boy” by Congressional aides. In working to develop the next federal budget, legislators again propose to deny annual CPI price updates for laboratory tests. This won’t be anything…
New Lab Test Technology Must Meet Five Payer Requirements
By Robert Michel | From the Volume IX No. 5 – April 1, 2002 Issue
HOSPITALS ARE NOT THE ONLY healthcare player wary of the high cost of new diagnostic test technologies. Insurance companies all over the United States have increased their scrutiny of new medical technology, including laboratory tests. In a visit to Wall Street last week, THE DARK REPORT attended …
FNA Clinic Business Becomes Part of Unilab
By Robert Michel | From the Volume IX No. 2 – January 28, 2002 Issue
CEO SUMMARY: Pathology has a new business model entering the marketplace. The goal of FNA Clinics of America, Inc. is to offer patients speedy access to the FNA procedure and provide referring physicians with a final diagnosis within hours of the FNA procedure. Unilab Corporation recogniz…
“July 23, 2001 Intelligence: Late Breaking Lab News”
Chairman and CEO Mark Chandler recently disclosed that researchers within Luminex Corporation are developing new detection capabilities that would permit its LabMap system to “simultaneously perform a broad range of cellular, microbial, and related tests, such as complete blood cou…
Medical Arts Lab Opts To File For Chapter 11 Bankruptcy
By Robert Michel | From the Volume VII No. 16 – November 13, 2000 Issue
CEO SUMMARY: Dissident shareholders and a crushing debt burden are the reason Medical Arts Laboratory decided to file for reorganization under Chapter 11 bankruptcy laws. Both factors are the legacy of an ill-fated attempt to create a national laboratory organization between 1994 and 1997…
CURRENT ISSUE

Volume XXXII, No. 13 – September 15, 2025
The Dark Report examines a new bill that would reform PAMA and avoid reimbursement rate cuts scheduled for January 2026. Clinical laboratory leaders are urged to make their voices heard in Congress. Also, an expert describes how labs can fix pre-analytical errors and avoid disaster.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized